Under-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program by Mugwaneza, Placidie et al.
Page number not for citation purposes  1 
 
 
 
Under-two  child  mortality  according  to  maternal  HIV  status  in  Rwanda:  assessing 
outcomes within the National PMTCT Program  
 
Placidie Mugwaneza
1,&, Nadine Umutoni Wa Shema
1, Hinda Ruton
1, Alphonse Rukundo
1, Alexandre Lyambabaje
2, Jean de Dieu 
Bizimana
3, Landry Tsague
4, Claire M Wagner5, Elévanie Nyankesha
4, Jane Muita
4, Vincent Mutabazi
1, Jean Pierre Nyemazi
1, Sabin 
Nsanzimana
1, Corine Karema
1, Agnes Binagwaho
5,6  
 
1Center for Treatment and Research on AIDS, Malaria, Tuberculosis and Other Epidemics, Kigali, Rwanda, 
2Department of Applied Mathematics, 
National University of Rwanda, Butare, Rwanda, 
3Development Research Group, World Bank, Washington DC, USA, 
4UNICEF Rwanda, Kigali, 
Rwanda, 
5Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA, 
6Ministry of Health of Rwanda, Kigali, Rwanda  
 
&Corresponding author: Placidie Mugwaneza, TRAC Plus, Boulevard de la Revolution, BP 2717, Kigali, Rwanda  
 
Key words: HIV, PMTCT, maternal HIV infection, infant mortality, child mortality, under-five mortality, Rwanda 
 
Received: 18/05/2011 - Accepted: 26/07/2011 - Published: 03/08/2011 
 
Abstract  
Introduction: We sought to compare risk of death among children aged under-2 years born to HIV positive mother (HIV-exposed) and to HIV 
negative mother (HIV non-exposed), and identify determinants of under-2 mortality among the two groups in Rwanda. Methods: In a stratified, 
two-stage cluster sampling design, we selected mother-child pairs using national Antenatal Care (ANC) registers. Household interview with each 
mother was conducted to capture socio-demographic data and information related to pregnancy, delivery and post-partum. Data were censored at 
the date of child death. Using Cox proportional hazard model, we compared the hazard of death among HIV-exposed children and HIV non-
exposed children. Results: Of 1,455 HIV-exposed children, 29 (2.0%; 95% CI: 1.3%-2.7%) died by 6 months compared to 18 children of the 
1,565 HIV non-exposed children (1.2%; 95% CI: 0.6%-1.7%). By 9 months, cumulative risks of death were 3.0% (95%; CI: 2.2%-3.9%) and 
1.3% (96%; CI: 0.7%-1.8%) among HIV-exposed and HIV non-exposed children, respectively. By 2 years, the hazard of death among HIV-
exposed children was more than 3 times higher (aHR:3.5; 95% CI: 1.8-6.9) among HIV-exposed versus non-exposed children. Risk of death by 9-
24 months of age was 50% lower among mothers who attended 4 or more antenatal care (ANC) visits (aHR: 0.5, 95% CI: 0.3-0.9), and 26% 
lower among families who had more assets (aHR: 0.7, 95% CI: 0.5-1.0). Conclusion: Infant mortality was independent of perinatal HIV exposure 
among children by 6 months of age. However, HIV-exposed children were 3.5 times more likely to die by 2 years. Fewer antenatal visits, lower 
household assets and maternal HIV seropositive status were associated with increased mortality by 9-24 months.  
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Introduction 
 
Mother-to-child transmission (MTCT) remains a major cause of pediatric human immunodeficiency virus (HIV) infection in sub-Saharan Africa, 
where more than 90% of the world’s 2.1 million HIV-infected children live [1]. If not provided with timely and appropriate antiretroviral therapy 
(ART), about half of these children will die before they reach two years of age [2]. Children can be infected by HIV during gestation, birth, and 
through breastfeeding. Studies have reported the direct impact of HIV on maternal health and wellbeing, and its negative impact on child survival 
even in the absence of mother-to-child transmission of HIV [2,3]. The use of antiretroviral drugs (ARV) in resource-limited settings has been 
proven effective both for prevention of mother-to-child transmission (MTCT) and treatment of adult and pediatric HIV diseases and is dramatically 
changing the face of the epidemic [4-12]. However, recent studies have established an increased risk of mortality among children who are exposed 
to HIV perinatally [13-18]. Until recently, few countries in sub-Saharan Africa had reported on the effectiveness of national PMTCT programs in 
terms of maternal and child survival benefits. Two studies in Malawi and Ghana reported on the effects of maternal HIV infection on child survival 
based on data from the 2003 Demographic and Health Survey [15,19]. However, these did not reflect the era following the introduction of more 
efficacious ARV regimens in PMTCT guidelines in 2006, which had accelerated access to antiretroviral therapy [20,21].  
  
Globally, the under-five mortality rate has dropped from 89 deaths per 1,000 live births in 1990 to 60 in 2009. And yet, approximately 8.1 million 
children under the age of five died in 2009 alone, and 50% of those deaths occurred in sub-Saharan Africa [22]. With 129 deaths per 1,000 live 
births, sub-Saharan Africa’s under-five mortality remains 20 times greater than the average in the developed world [22]. A multi-country pooled 
analysis indicated that HIV accounted for 5.4% and 3.6% of under-5 deaths in sub-Saharan Africa between 1990 and 2009, respectively, showing 
a decrease of the contribution of HIV to under-five mortality. This trend is very encouraging, but more efforts are required in order to achieve the 
fourth Millennium Development Goal (MDG4), which calls for a two-thirds reduction of the under-five mortality rate between 1990 and 2015, to 
which HIV is a contributing factor [22]. Rwanda has registered a dramatic decline in its under-five mortality rate from 152 to 103 deaths per 1000 
live births within a five year period [23,24].  
  
Rwanda has an HIV prevalence estimated at 3% in the general population, accounting for an estimated 174,000 people, including 22,000 children 
[23,25]. Were no interventions available to prevent mother-to-child transmission (PMTCT), 3,850 children among the 11,000 children born to the 
estimated 11,000 HIV-positive mothers in Rwanda would be infected with HIV [26]. The first PMTCT project in Rwanda began in 1999, followed by 
the National PMTCT program which was established in 2001 by the Ministry of Health. Since 2001, ARV regimens used in Rwanda have been in line 
with those recommended by the World Health Organization.  
  
From  2001-2005,  single  dose  Nevirapine  (NVP)  was  utilized  as  the  prophylaxis.  In  September  2005,  Rwanda  adopted  the  second  WHO 
recommendations for PMTCT regimens based on dual therapy including Zidovudine (AZT) and Nevirapine, By 2009, the national PMTCT program’s 
services  could  be  accessed  in  72%  of  all  health  facilities.  An  estimated  65%  of  HIV-positive  pregnant  women  were  receiving  ART  or  ARV 
prophylaxis for PMTCT in 2009 [27], and about half were on dual ARV prophylaxis. The national PMTCT program implemented between 2005 and 
2009 is described in further detail elsewhere [28]. In November 2010, Rwanda adopted the “Option B” of the 2010 WHO recommendations for the 
use of ARV in PMTCT; therefore, all HIV-positive pregnant women will receive triple ARV therapy (HAART) starting as soon as possible during 
pregnancy for all women eligible for lifelong triple therapy and from 14 weeks into pregnancy for women not eligible for lifelong treatment.  
  
Although some underlying factors associated with under-five child mortality in Rwanda are known (e.g. mother’s education, and mother’s socio-
economic status [23,24]), little is known on the mortality outcomes of HIV-exposed children in Rwanda. The paucity of data on the contribution of 
HIV to current under-five mortality in Rwanda has stagnated the development and implementation of targeted interventions. In this study, we 
sought to analyze whether children born to HIV-positive mothers have a higher risk of mortality than children born to HIV-negative mothers; and 
to understand factors associated with mortality in order to inform national efforts to accelerate the reduction of child mortality. There is currently 
no indicator in Rwanda’s Demographic and Health Survey on under-two mortality. The under-two mortality rate also contributes to the under-five 
mortality rate. As such, we employ under-five mortality as a proxy unit of comparison.  
  
  
Methods 
 
Study design  
  
This retrospective cohort study is based on a cross-sectional survey of HIV-positive and HIV-negative mothers and their children.  
  
Study population  
  
The participants included both mothers and children. Mother participants were HIV-positive or HIV-negative and expecting a child (or children) 
between March 2007 and June 2008; these only included mothers for whom at least one ANC visit was recorded. Maternal HIV status was 
determined by HIV rapid test and the national algorithm used at the time of the study, which included three tests: Determine, Unigold and 
Capillus. Child participants included the mothers’ children who were born during the aforementioned dates. Health facilities that were not providing 
PMTCT services, in addition to those who had not been providing PMTCT services for fewer than 36 months, were excluded from the study. 
Mothers  who  had  not  had  at  least  one  ANC  visit  and/or  who  were  not  expecting  a  child  between  the  provided  dates  were  excluded  from 
participation. Children whose mothers were not participants in the study were excluded from the study.  
  
A stratified two-stage cluster sampling method was used to select participants. First, health centers that had offered PMTCT services for at least 36 
months prior to the survey were stratified dichotomously into urban and rural groups. Second, a random sample of health centers was selected 
from each stratum. Mothers were divided into three groups: HIV-positive mothers who had completed at least 4 ANC visits, HIV-positive mothers 
who did not complete 4 ANC visits; and HIV-negative mothers. As the recruitment was based on data from ANC registries, it was assumed that Page number not for citation purposes  3 
women with 4 ANC visits were more likely to comply with other PMTCT program activities than women who had not completed 4 ANC visits. Third, 
the mother-child pairs were randomly selected from each group and then tracked back to their homes for interviews. A transmission rate of 35% 
without intervention was assumed according to UNAIDS estimates [26], and a 10% reduction in transmission was assumed with intervention (25% 
transmission) given that estimates in Rwanda were not available at the time of the study. The 25% and 35% respective transmission rates allowed 
for a robust sample size calculation that met requirements for a 5% significance level, an 80% statistical power, an assumed 10% non-response 
rate, and a design effect of 2. Accordingly, a sample size of 3,420 mother-child pairs was required. The methodology was approved by the National 
Institute of Statistics of Rwanda.  
  
Data collection  
  
At  the  household  level,  data  were  collected  using  two  instruments:  a  questionnaire  for  mothers  and  a  child  health  assessment  card.  The 
questionnaire was developed and the outcome and predictor variables were selected based on a literature review. The questionnaire was further 
refined in close collaboration with PMTCT professionals in Rwanda. Methods were pretested and  revised accordingly. The questionnaire was 
administered in Kinyarwanda, the only local language in Rwanda. Interviews were conducted over the period of 45 minutes on average. This 
questionnaire was used to capture information about the knowledge of mothers about HIV (with a particular focus on PMTCT), the use of PMTCT 
services by HIV-positive women, and the use of reproductive health services. Several variables including number of ANC visits, ARVs taken by 
mother and child, place of delivery, and feeding options were measured using this questionnaire. The child health assessment card was used to 
record child basic demographics such as age and sex, overall health, as well as weight, height and HIV status.  
  
The data presented in this article derive from a larger study on child health and HIV/AIDS in Rwanda. Blood samples were collected at the 
household level from child participants who were alive at the time of data collection. However, for the purposes of the present findings, and given 
that not all child participants were alive at the time of data collection, the child’s HIV status was not included for the analysis in this article. Further, 
the cut-off of 9-24 months was chosen as part of the larger study on child health and HIV/AIDS in Rwanda wherein the child’s HIV status between 
the ages 9-24 months was required for analysis. In Rwanda, the national PMTCT guidelines mandate the first HIV test for children born to HIV-
infected mothers and HIV-discordant couples be administered at 6 weeks using the Polymerase Chain Reaction (PCR). The second and third tests 
are administered at 9 and 18 months, respectively, using the HIV rapid test. At the time of data collection, the test at 6 weeks had not been 
implemented in all health facilities that had been offering PMTCT services for the past 36 months. As such, the cut-off of 9 months was chosen to 
enable the HIV rapid test data to be used. The cut-off of 24 months was used according to PMTCT guidelines in Rwanda as a month wherein HIV-
exposed children attend follow-up visits at the health facility.  
  
Data management and analysis  
  
Completed questionnaires were periodically brought in from the field to the School of Public Health of the National University of Rwanda for data 
entry. Data were entered using CSPro 4.0. A quality control program was used to detect errors in data collection and data entry. This information 
was  shared  with  field  teams  during  supervisory  visits  and  weekly  meetings  were  held  to  improve  data  quality.  In  addition,  10%  of  the 
questionnaires were double-entered for data quality control at entry. Data was exported to STATA 10.1 for data analysis. We used descriptive 
statistics to describe essential demographic, social, and economic characteristics of participants.  
  
Primary study endpoint  
  
The primary study endpoint was the cumulative risk of death among children 9-24 months old according to maternal HIV status. Secondary 
endpoints included social, and economic and behavioral factors that were associated with child mortality.  
  
Maternal predictor variables  
  
The potential predictor variables included socio-demographic characteristics of the mother; indices for decision-making power about health and 
nutrition as well as decision-making power about short and long term investment strategies, housing material, household assets; in addition to 
household size, access to clean water, location of household, and ANC utilization.  
  
The risk of death among children born to HIV-infected mothers was compared to the risk of death among children of the same age born to HIV-
negative mothers. As stated above, the purpose of this comparison was to determine if children born to HIV-infected mothers might be at higher 
risk of death than the rest of the children of the same age. All confidence intervals (CI) were at the 95% level of significance, and P-values of 0.05 
and below were considered statistically significant. Kaplan-Meier survival analysis and log rank test were used to assess the difference in survival 
between children born to HIV-positive mothers and those born to HIV-negative mothers (Figure 2). We modeled the risk of dying by 9-24 months 
among children born to HIV-infected mothers using a Cox proportional hazard regression model. Categorical independent variables were coded as 
dummy variables in the regression model. Stepwise selection with a probability of 0.05 for a variable to enter the model and a probability of 0.15 
to be removed from the model were used to test the model of the determinants of hazard of death among children. The final model included three 
variables: mother’s HIV serostatus, the number of ANC visits, and ownership of assets index (Table 3).  
  
Ethical considerations  
  
Appropriate measures were taken to ensure survey participant protection, signed and informed consent, voluntary participation and confidentiality. 
In addition, formal review and approval of the instruments were obtained from the Rwandan National Ethics Committee.  
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Results 
 
Description of survey participants  
  
One hundred and five health facilities were selected and visited. Of 3,020 children selected, 1,455 (48.2%) were HIV-exposed and 1,565 (51.8%) 
were not exposed to HIV (Figure 1). Twenty-six percent of HIV-positive mothers and 14% of HIV-negative mothers could not be interviewed for 
this study; the total non-response rate was 20%.  
  
The mean ages of HIV-positive and HIV-negative mothers interviewed were 32.2 years and 30.1 years, respectively. The majority of HIV-positive 
and negative mothers (78.3% and 68.9%, respectively) were between 25 and 39 years old. Among all mothers, the majority were also living with 
a partner (68.9% of HIV-positive and 87.5% of HIV-negative mothers). Among HIV-positive mothers, 67% had a primary school education, and 
among HIV-negative mothers 69.4% had a primary school education. The study found that 55.1% of HIV-positive and 59.9% of HIV-negative 
mothers were able to read and write easily (Table 1). About 80% of mothers (HIV-positive or HIV-negative) lived in rural areas.  
  
Child mortality according to maternal HIV status  
  
A total of 61 out of 1,455 children born to HIV-positive mothers died by 9-24 months compared to 24 out of 1,565 children born to HIV-negative 
mothers. The cumulative risk of death was almost three times higher in children born to HIV-positive mothers than in those who were born to HIV-
negative mothers (4.2% vs. 1.5%; p 
  
Twenty-nine out of 1,448 children born to HIV-positive mothers (2.0%; 95% Confidence Interval: 1.3%-2.7%) died before the age of 6 months 
compared to 18 out of 1,565 children born to HIV-negative mothers (1.2%; 95% CI: 0.6%-1.7%). No statistically significant difference in risk of 
dying by 6 months of age was observed between the two groups. By the age of 9 months, a total of 44 children out of 1,448 children born to HIV-
positive mothers died; the cumulative risks of death were estimated at 3.0% (95% CI: 2.2%-3.9%) vs. 1.3% (95% CI: 0.7%-1.8%) for children 
born to HIV-positive and HIV-negative mothers, respectively. The difference in risk of dying by 9 months of age observed between the two groups 
was statistically significant (p=0.01).  
  
Before the age of six months, mortality rates were similar in the two groups. However, after the age of six months, children born to HIV-positive 
mothers were at a higher risk of death than children born to HIV-positive mothers. According to the Kaplan-Meier survival analysis (Figure 2), 
children born to HIV-positive mothers were less likely to survive until 9-24 months than children born to HIV-negative mothers (p 
  
Maternal characteristics associated with death among under-2 years children  
  
In univariate analysis, excluding maternal HIV status, household assets were significantly associated with death (Table 2). Ownership of assets 
was significantly lower on average in households that had lost the child (or children) compared to households whose child was (or children were) 
still alive at the time of the survey (mean assets: 0.8 vs. 1.0, p=0.033). The comparison of household assets to maternal or child HIV status was 
beyond the scope of this study. The remaining background characteristics (maternal age, marital status, literacy, and decision-making power) did 
not have a significant association with child mortality (Table 2).  
  
In multivariate analysis (Table 3), the hazard of death among under-2 years children born to HIV-positive mothers was 3 times higher than it was 
among children born to HIV-negative mothers (adjusted Hazard Ratio; aHR: 3.5, 95% CI: 1.8-6.9). The hazard of death was 50% lower among 
children whose mothers had 4 or more ANC visits than among children whose mothers visited ANC services not more than once (aHR: 0.5, 95% 
CI: 0.3-0.9). Furthermore, the final model indicated that more assets owned by a household was associated with lower risk of death in children 
(aHR: 0.7, 95% CI: 0.5-1.0).  
  
  
Discussion 
 
The present study is the first to report and compare mortality among HIV-exposed and HIV non-exposed children up to 2 years of age in a national 
PMTCT program in resource limited settings. The cumulative risk of death was 2.0% (95% CI: 1.3%-2.7%) by 6 months among HIV-exposed 
children and comparable to 1.2% (95% CI: 0.6%-1.7%) among HIV non-exposed children. By 9 months, the cumulative risk of death increased 
notably to 3.0% (95% CI: 2.2%-3.9%) among HIV-exposed children compared to 1.3% (96% CI: 0.7%-1.8%) among HIV non-exposed children. 
By 2 years, the cumulative risk of death reached 4.2% (95% CI: 2.2%-3.9%) among HIV-exposed children compared to 1.5% (96% CI: 0.7%-
1.8%) among HIV non-exposed children. By 2 years, the hazard of death among HIV-exposed children was more than 3 times higher (aHR: 3.5, 
95% CI: 1.8-6.9) compared to HIV non-exposed children. Risk of children death by 2 years of age was 50% lower among mothers who attended 4 
or more antenatal care (ANC) visits (aHR: 0.5, 95% CI: 0.3-0.9), and 26% lower among families who had more household assets (aHR: 0.7, 95% 
CI: 0.5-1.0).  
  
The mortality rate among HIV-exposed children in Rwanda is less than half of the rate reported from a pooled analysis of 3,468 HIV-exposed 
children in Africa showing an 11% mortality rate [2]. Although two years cumulative risk of death among HIV-exposed children is nearly three 
times higher than among HIV non-exposed children, it remains lower than the baseline infant mortality (6.2%) and under-five mortality rates 
(10.3%) in Rwanda [29].  
  
In our study, maternal HIV status was associated with an increased risk of death (3.5 times) among under-two year children. Our findings are 
consistent with previous reports showing higher mortality (2.2-6.3 times) among children born to HIV-positive mothers compared to children born 
to HIV-negative mothers [2,15,30-33]. But no published studies reported mortality by 2 years, but mainly by 6 months. During the first 6 months Page number not for citation purposes  5 
of life, our study evidenced that mortality was low and independent from maternal HIV status. The low 6-month mortality (2.0%; 95% CI: 1.3%-
2.7%) among HIV-exposed children from our study could be attributed in our context to the scaling up of various interventions including the 
PMTCT programs (roll-out of more efficacious ARV regimens including HAART for eligible pregnant women), promotion of exclusive breastfeeding 
for the first 4-6months, as well as increased access to cotrimoxazole [34] and ARV prophylaxis or treatment for HIV-exposed or infected children 
[35].  
  
However, mortality significantly increased after 6 months among HIV-exposed children – a finding similar to those in other sub-Saharan African 
countries. These reports demonstrate early weaning at 4–6 months of age to be the most important and modifiable risk factor for infant mortality 
among HIV-exposed children after 6 months of age [36-39]. The infant feeding guidelines in Rwanda were aligned with the WHO guidelines of 
2003 which recommended exclusive breastfeeding with rapid weaning at 4-6 months for HIV-exposed children when all the criteria to formula feed 
from birth were not met [21].  
  
In a trial on the effect of early weaning on child health outcomes in Zambia, authors reported that children who died by 24 months were more 
likely to have mothers with low CD4 counts and high viral loads, and were more likely to have had mothers who died, as compared to children who 
did not die by 24 months [40]. This study demonstrated the important role maternal health plays as determinant of child survival. Without 
antiretroviral treatment, half of all HIV-infected children would die within the first 2 years of life [41]. Our study did not measure access to 
treatment for eligible women during pregnancy, nor did we assess early infection in children (6 weeks old) or children’s HIV status at the time of 
death. However, we hypothesize that maternal health and treatment for HIV-infected children did not play a significant role on the increased child 
mortality after 6 months in our study. Shorter breast-feeding (or no breast-feeding) may increase mortality from common childhood illnesses 
[36,39] and could be more detrimental for HIV-exposed but uninfected children. Mortality rates among HIV-exposed but uninfected children have 
been reported to exceed rates among HIV non-exposed children, even when feeding patterns are similar; intensive nutritional and counseling 
interventions reduce but do not eliminate this excess mortality [30,31,33,40,41].  
  
From a public health standpoint, our findings support the recent revision of the PMTCT and infant feeding guidelines in Rwanda which promote 
improved maternal health, and extended breastfeeding with antiretroviral prophylaxis during 18 months [42]. Exclusive breastfeeding of HIV-
exposed children is recommended for the first six months with the introduction of healthy, balanced, and appropriate complementary food at six 
months  and  continuation  of  breastfeeding  without  exceeding  the  maximum  recommended  duration  of  18  months.  Weaning  should  be  done 
gradually over a period of one month in conjunction with advice and nutritional support.  
  
In our study, higher frequency of ANC visits is associated with lower risk of death in children. Similarly, in a study conducted in Ghana, children 
born to mothers who did not receive antenatal care were 1.7 times more likely to die before reaching their first birthday than children of mothers 
who did receive antenatal care [15]. Receiving prenatal care was also found to be associated with lower risk of infant mortality in Bangladesh [43].  
  
Another significant factor in child mortality evidenced in our study and in the current literature concerns household assets. The present research 
found that more assets owned by a household are associated with lower risk of death in children. Similarly, a study conducted in Cambodia 
revealed that children born in the poorest 40% of households were more than twice as likely to die during infancy as those born in the richest 20% 
of households [44]. During a clinical trial on child health outcomes in Zambia, authors reported that children who died were more likely to have 
lived in households reporting food insecurity and with more than one child under 5 years of age [40]. A number of studies found an association 
with maternal health care seeking behavior and household wealth. In a study conducted in Bangladesh among rural women, 22% of those in the 
lowest wealth quintile and 69% in the highest quintile reported having sought antenatal care from a medically trained provider [45]. Another study 
in Bangladesh found that low household asset status was a major determinant of health-seeking behavior [46].  
  
Our analysis was based on data collected from a household survey of mothers selected from ANC registers in PMTCT sites. Even those women who 
had had only one ANC visit were included in the study sample. According to the 2007-08 Rwanda Interim Demographic and Health Survey, 94% of 
women who had live births in the past five years received ANC [24] from trained health personnel at least once. Thus, our sample was drawn from 
94% of pregnant women in Rwanda. Given that 73% of women attending ANC visit were offered HIV testing in Rwanda [47], we were able to 
identify our sample from 68% of the all mothers who delivered a live birth infant from March 2007 to June 2008.  
  
Our study is representative of all women who had attended at least one ANC visit in PMTCT program sites, and we used a robust two-stage cluster 
sampling approach. Yet we excluded some health facilities that had been offered PMTCT services for less than 36 months. Mothers who did not 
consult ANC services were also excluded from the study, and thus did not represent all expecting women during this timeframe. As part of the 
larger study from which these data on mortality derived, HIV tests were administered at the household level to those children who were still alive 
at the time of the study. However, given the retrospective nature of the study, many child participants had died at the time of the data collection. 
Therefore,  it  was  not  possible  to  link  the  child’s  death  to  his  or  her  HIV  status.  It  is  uncertain  as  to  whether  mothers  completely  stopped 
breastfeeding at 9 months, which could confound the data analysis on weaning and survival. Although most mothers responded to all questions, 
the absence of responses from some participating mothers is an additional limitation. Finally, recall bias concerning PMTCT service use may have 
influenced study findings.  
  
Further studies should be conducted to fill current gaps in the literature. A longitudinal study on a cohort of children born to HIV-positive and HIV-
negative mothers who come for infant immunization at 6 weeks, and HIV tests and follow-up visits until 24 months, would be beneficial. This 
would diminish recall bias and fit into the regular health visits of a family. In addition, a multivariate analysis comparing ANC utilization to maternal 
characteristics would be a valuable addition to current scientific literature on child mortality.  
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Conclusion 
 
Exposure to HIV has been recently reported to contribute to 3.6-4.0% of under-five mortality in sub-Saharan Africa [48,49]. In Rwanda, this would 
translate  into  1,200  under-five  deaths  due  to  HIV  out  of  the  41,200  under-five  deaths  from  a  hypothetical  400,000  annual  live  births.  The 
prognosis for HIV-exposed children is comparable to that of HIV non-exposed children before 6 months of age. However, the risk of dying is 
significantly higher by 9-24 months old among HIV-exposed children. All HIV-exposed children should be targeted with child survival interventions 
in order to decrease the mortality differential existing between HIV-exposed and HIV non-exposed children. To reduce infant and child mortality, 
particularly HIV-related mortality, it is necessary to ensure that the revised infant feeding guidelines and communication strategies be implemented 
to prevent continuation of abrupt weaning practices. Rwanda will also need to increase the demand for and access to ANC visits by mothers. 
Further, integration of targeted social protection strategies will promote equity in access to effective child survival interventions for children born 
into families with a low household asset score. Our findings provide data required for Rwanda to better guide programmatic interventions targeting 
child mortality in the context of HIV/AIDS.  
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Table 1: Background Characteristics of HIV-positive and HIV-negative mothers expecting a child between March 2007 and June 2008.  Rwanda, 2009     
Characteristics        HIV-positive mothers    HIV-negative mothers 
         Number  %    Number  % 
Mother’s age  (years)                 
  
  
  
  
15-24     143  10.0    330  21.5 
25-29     354  24.7    473  30.8 
30-34     415  29.0    347  22.6 
35-39     351  24.5    239  15.5 
40-44     141  9.9    120  7.8 
45-49     27  1.9    29  1.9 
Total     1,431      1,538   
Mean age       32.2      30.1 
                          
Marital Status  Single/Never married                            122  8.5    97  6.3 
Lives  with a partner     986  69.0    1,345  87.7 
Separated/Divorced/Widowed     321  22.5    92  6.0 
   Total     1,429      1,534   
                  
Religion  No religion     23  1.6    14  0.9 
Adventist     141  9.9    152  9.9 
Catholic     609  42.5    703  45.7 
Protestant     582  40.6    631  41.0 
Muslim     60  4.2    26  1.7 
Others     17  1.2    12  0.8 
   Total     1,432      1,538   
Education                 
   Never attended school     353  24.7    354  23.0 
Primary school     965  67.6    1,068  69.5 
Vocational/technical      37  2.6    27  1.8 
Secondary school     69  4.8    87  5.7 
University      4  0.3    1  0.1 
   Total     1,428      1,537   
Literacy                 
   cannot read and/or write; or has difficulty 
reading and/or writing 
   573  40.0    556  36.2 
cannot read and/or write; or has difficulty 
reading and/or writing 
   69  4.8    61  4.0 
can read and write easily     789  55.1    921  59.9 
   Total     1,431      1,538   
Residence Location                 
   Rural     1141  79.6    1,252  80.9 
Urban     293  20.4    296  19.1 
Total     1,434      1,548   
                  
Membership  to  a  PLWH 
association 
Yes     775  54.7       
No     642  45.3       
   Total     1,417         
              
Housing index, (n=2882)     Mean (SD)      
   HIV + mothers     1.38(0.82)      
   HIV – mothers     1.43(0.82)      
         
Household asset index (n=2948)  Mean (SD)      
   HIV + mothers     0.89 (1.04)      
   HIV – mothers     1.16 (1.11)      
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Table  2:  Cumulative  mortality  among  HIV-exposed  and  non-exposed  children  by  maternal  and 
household characteristics 
  
Maternal characteristics  Dead (%)  Alive (%)  P-value 
        
HIV serological status (n=3,020) 
HIV-positive 
HIV-negative 
 
4.2 
1.5 
 
95.8 
98.5 
 
<0.001 
        
Age, years (n=3,007 ) 
15-24 
25-29 
30-34 
35-39 
40-44 
45-49 
 
3.2 
1.9 
3.0 
3.5 
3.0 
3.6 
 
96.8 
98.1 
97.0 
96.5 
97.0 
96.4 
 
 
 
 
0.567 
        
Marital status (n=3,001) 
Single/never married 
Lives with a partner 
Separated/divorced/widowed 
 
4.0 
2.6 
3.3 
 
96.0 
97.4 
96.7 
 
 
0.361 
        
Literacy (n=3,006) 
can't or have difficult reading and/or writing 
can read but can't or have difficult writing 
can read and write easily 
 
3.2 
3.8 
2.5 
 
96.9 
96.2 
97.5 
 
 
0.492 
         
Decision-making power
#        
Health and nutrition issues means (n=3004)  90.65  89.48  0.590 
Short and long term investment strategies means 
(n=3004)  
83.43  82.95  0.872 
        
Household characteristics Location, % (n=3020)       
Urban 
Rural 
3.4 
2.7 
96.6 
97.3 
 
0.373 
        
Housing index
@, mean(SE) (n=2920)  1.3  1.4  0.357 
Household assets index
$, mean(SE) (n=2984)  0.8  1.0  0.033 
        
Access to clean water, % (n=2966) 
Yes 
No  
 
2.7 
3.1 
 
97.3 
96.9 
 
0.596 
           
# Decision-making power about health and nutrition index is defined as a composite index created to measure the extent 
to which the respondent is involved in making household decisions related to health and nutrition issues. Scores ranged 
from 0 – 100 and a higher score indicates greater decision-making power. Decision-making power about short and long-
term investment strategies index is defined as a composite index created to measure the extent to which the respondent 
is involved in making household decisions related to short and long-term investment issues. Scores ranged from 0 – 100 
and a higher score indicates greater decision-making power. 
@Housing material index is defined as a composite index indicating whether roof, walls, and floors of the respondent’s 
house is built in durable materials. The index ranged from 0 to 3; 0 meaning that none of the housing materials is durable 
while 3 meaning that materials for roof, walls and floors are durable.  
$  Household  asset  index  is  defined  as  a  composite  index  indicating  the  number  of  valuable  equipments  owned 
(Refrigerators, mobile telephone, radio, TV, car, etc). 
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Table 3: Cox proportional hazard regression models of time to death and factors associated with variability in time to death 
among under-2 years HIV-exposed and non-exposed children 
   Adjusted Hazard ratio  95% CI 
Mother’s HIV status during pregnancy (reference: HIV-negative)     
HIV-positive   3.51  1.78– 6.89 
      
Number of ANC visits (reference: fewer than 4)     
4 or more  0.50  0.26 – 0.93 
      
Household asset index  0.74  0.54 – 1.03 
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